Dallas, TX (PRWEB) September 11, 2012
Primcogent Solutions, dedicated to offering healthcare products to the medical community backed by a clear, logical, and convincing scientific and clinical foundation, announces that ZERONA LLLT has been featured on the cover of THE Aesthetic Guide Magazine, the leading aesthetic practice resource, to announce the industry-first ZERONA-AD device FDA cleared for reduction in circumference for the upper arms.
The article focuses on ZERONA-AD, a newly FDA cleared device for the circumferential reduction of the upper arms, which is an aesthetic industry first. Additionally, the article examines the strong scientific foundation of this technology by examining ZERONA’s 17 peer-reviewed publications that validate its mechanism of action and clinical utility. Further supporting ZERONA’s clinical utility, numerous world-renowned physicians – Jamé Heskett, M.D.; Patricia Ogilvie, M.D.; R Stephen Mulholland, M.D.; Robert F. Jackson, M.D.; and Mark S. Nestor, M.D., Ph.D. – discuss their experience with the technology and dispel common misconceptions.
“We are pleased with ZERONA’s cover feature in the July/August issue of THE Aesthetic Guide,” said Michael Browning, Senior Vice President of Global Marketing and Business Development at Primcogent Solutions. “This publication only reinforces ZERONA’s acceptance as an effective non-invasive body contouring treatment by leading physicians throughout the world.”
To learn more about ZERONA LLLT please visit http://www.primcogent.com.
About Primcogent Solutions
Primcogent Solutions is dedicated to offering healthcare products to the medical community backed by a clear, logical, and convincing scientific and clinical foundation. Primcogent Solutions’ products, ZERONA LLLT, manufactured by Erchonia Medical is the only platform that is FDA cleared for the safe and effective simultaneous reduction of fat from the hips, waist, thighs, and upper arms. Primcogent Solutions’ revolutionary non-invasive body contouring technology, along with its unique physician business model, enhances practice profitability by eliminating the risks associated with purchasing capital equipment. For more information, visit http://www.primcogent.com.
Erchonia is the global leader in low-level laser healthcare applications. Over the last 15 years Erchonia has been conducting research and development with the world’s leading physicians to advance the science of low-level lasers. Prior to market introduction, all Erchonia lasers are proven safe and effective through independent clinical trials. Currently, thousands of Erchonia’s lasers are used daily to reduce body fat, eliminate pain, accelerate healing, and treat acne. For additional information, visit http://www.erchonia.com.